QRHC Quest Resource Holding Corp Insider Trading

Director Friedberg buys 8,500 shares of QRHC at $0.87; stock down 58.7% from 52-week high, unprofitable fundamentals, insider's prior QRHC trades underwater at 90 days.

Director Daniel M. Friedberg purchased 8,500 shares at $0.87 on 2026-03-19, increasing holdings by 20.9% to 49.1K shares. The purchase occurs in a deteriorating context: the company is unprofitable (net income $-1.3M in latest quarter, annual revenue declining 13.3%), and the stock has fallen 58.7% from its 52-week high of $3.05 to a current price of $1.26. Friedberg's prior trades at QRHC present a cautionary pattern—both his 2025-03-19 and 2025-03-18 buys generated 90-day losses of 28.4% and 28.1% respectively, and 0 of 2 prior measurable QRHC buys produced positive 90-day returns. His cross-ticker track record shows an 0.00% win rate at the 90-day mark with a -28.2% average loss, suggesting systematic difficulty in entry timing. A cluster of 2 other insider buys within the past 14 days indicates multi-executive accumulation despite negative fundamentals and price weakness.

Director Robert J Lipstein bought 11,000 shares of QRHC at $0.90 on 2026-03-18; stock now $0.88, -71.2% from 52-week high.

Director Robert J Lipstein purchased 11,000 shares at $0.90 on 2026-03-18, increasing his holdings from 37,500 to 48,500 shares (+29.3%). The purchase occurs in the context of significant price deterioration: the stock trades at $0.88 today, down 71.2% from its 52-week high of $3.05, and has declined 53.9% over the past 30 days and 58.1% over 90 days. This buy coincides with a cluster pattern—2 other insiders also bought within the past 14 days. However, the company backdrop is concerning: it reported negative net income of $-1.3M in the latest quarter, operates on negative full-year earnings, and generated annual revenue growth of -13.3% year-over-year with a market cap of only $18.4M. Lipstein's prior open-market buy at this ticker (August 2025) posted a -9.8% 90-day return, establishing no pattern of well-timed entry points at QRHC.

Director Culpepper Glenn buys 5,000 shares of QRHC at $1.16; stock now at $0.88, -71.2% from 52-week high, -61.4% in 90 days.

Culpepper Glenn, a director of Quest Resource Holding Corp, purchased 5,000 shares at $1.16 on 2026-03-16, increasing his holdings from 56.6K to 61.6K shares. The transaction occurred at a time when the stock was trading 71.2% below its 52-week high of $3.05 and has since declined further to $0.88, a 24.1% drop in approximately two weeks. The company is currently unprofitable with a negative net income of $1.3M on quarterly revenue of $63.3M, and annual revenue declined 13.3% year-over-year, signaling operational stress. His prior four trades at this ticker show a 0% win rate on 90-day returns, with an average 90-day outcome of approximately -22.8%, suggesting his recent buys have not preceded recoveries in the stock.

Director Glenn Culpepper bought 5,000 shares of QRHC at $1.96 on 2025-12-23; stock now at $1.95, down 70.0% from 52-week high.

Culpepper Glenn, a director of Quest Resource Holding Corp, purchased 5,000 shares at $1.96 on 2025-12-23, increasing his holdings to 56.6K shares and representing a +9.7% increase in his position. The stock is currently trading at $1.95, down 70.0% from its 52-week high of $6.50, while the company posted a negative net income of $-1.3M against revenue of $63.3M in its latest quarter and has zero annual revenue growth. His prior three purchases at this ticker (most recently on 2025-08-14, 2024-12-23, and 2024-05-16) all proved disadvantageous within 90 days, with outcomes of -8.9%, -51.8%, and -17.7% respectively, establishing a 0 of 3 success rate on timing at this ticker. The sequence of accumulation into a depressed and unprofitable security warrants examination of whether this transaction signals conviction or reflects a pattern of poorly-timed entry decisions.

10% owner KITT BARRY M bought 199,759 shares across 3 transactions for $260,592.65 at blended avg $1.30, raising stake 8.0%

KITT BARRY M, a 10% owner, executed 3 separate purchases totaling 199,759 shares between October 23–27, 2025, at prices of $1.26, $1.33, and $1.36 (blended average $1.30), increasing his holding from 2,492,489 to 2,692,248 shares. The stock is now trading at $1.35, down 83.6% from its 52-week high of $8.24 and down 36.9% over the trailing 90 days. QRHC remains unprofitable (net income $-1,971,000.00 for the latest quarter) with flat annual revenue growth at +0.0%, and carries a modest market cap of $27,961,475.40. The accumulation during a period of sustained downward price movement and structural underperformance warrants examination of whether the insider views the depressed valuation as attractive or whether other material developments are anticipated.

Director Dunning Audrey bought 4,000 shares of QRHC at $1.82 on 2025-09-02; stock now -79.9% from 52-week high of $9.04.

Dunning Audrey, a director, purchased 4,000 shares at $1.82, increasing her holdings from 48.5K to 52.5K shares. The timing follows a steep price decline: the stock is trading at $1.82, down 79.9% from its 52-week high of $9.04 and down 13.3% over the prior 30 days. However, her prior four trades at QRHC show a poor track record: three of the four resulted in negative 90-day returns (ranging from -30.3% to -3.2%), with only one trade achieving a modest positive return of 1.6%. Across her cross-ticker buy history, the 90-day win rate was 20.00%, suggesting this pattern is not ticker-specific anomaly. Fundamentally, the company remains unprofitable with net income of -$2.0M against revenue of $59.5M, and annual revenue growth is flat at 0.0%, providing limited margin-of-safety context for the director's accumulation.

Director FRIEDBERG DANIEL M. bought 17,232 shares of QRHC at $1.60 on 2025-08-20; stock now -81.4% from 52-week high amid cluster buy pattern.

Director FRIEDBERG purchased 17,232 shares at $1.60 on 2025-08-20, bringing his holdings to 2,842,353 shares. The stock has declined sharply, down -81.4% from its 52-week high of $9.04 and trading -22.9% lower over the past 30 days. His prior two purchases at QRHC (2025-03-19 and 2025-03-18) both experienced negative returns at the 90-day mark, with respective declines of -28.4% and -28.1%. The company reported net income of $-1,971,000.00 for the latest quarter and zero year-over-year revenue growth, signaling fundamental weakness. The fact that 2 other insiders also bought within the past 14 days indicates a cluster buy pattern, but the insider's consistent pattern of poorly-timed purchases and the company's unprofitability and depressed valuation require scrutiny.

Director Lipstein Robert J bought 15,000 shares of QRHC at $1.70, increasing holdings 66.7% to 37,500 shares amid stock down 81.4% from 52-week high.

Director Robert J Lipstein purchased 15,000 shares at $1.70 on 2025-08-14, a substantial accumulation that increased his holdings by 66.7% from 22,500 to 37,500 shares for a total transaction value of $25,437.00. The purchase occurs with QRHC trading at $1.68 (current), down 81.4% from its 52-week high of $9.04 and down 27.9% over the past 90 days, at the lower end of the 52-week range. Lipstein's cross-ticker open-market track record shows 1 prior buy with an average 90-day return of +32.2% and a 100.00% win rate, though this cross-ticker data point does not establish predictive confidence for QRHC specifically. The company reported Net income of $-2.0M against Revenue of $59.5M in the latest quarter, with zero annual revenue growth and negative full-year net income, presenting a backdrop of ongoing operational underperformance rather than an unexpected crisis.

Director Culpepper Glenn buys 5,000 shares of QRHC at $1.68; stock down -81.4% from 52-week high of $9.04.

Culpepper Glenn purchased 5,000 shares at $1.68 on 2025-08-14, increasing his holdings to 51.6K shares (+10.7% from 46.6K). The stock is trading -81.4% below its 52-week high and has declined -16.8% over 30 days and -27.9% over 90 days. Glenn's prior trades at QRHC show weak execution: a December 2024 buy resulted in a -51.8% 90-day return, and a May 2024 buy resulted in a -17.7% 90-day return, with 0 of 2 prior buys well-timed at the 90-day mark. The company reported unprofitable operations with $-2.0M net income in the latest quarter and zero annual revenue growth. The pattern of repeated purchases into a declining stock coupled with poor historical timing outcomes and deteriorating fundamentals suggests limited conviction signals from this transaction.

Director Friedberg buys 12,574 shares at $2.95–$2.96 amid cluster of 4 other insider buys in 14 days; stock down 72.4% from highs.

Director Daniel M. Friedberg purchased 12,574 shares (2 separate transactions totaling $37,098.16) at an average price of $2.95, bringing his holdings to 2,825,121 shares. This activity is part of a cluster pattern with 4 other insiders also buying within the past 14 days. The context is notable: the stock trades at $2.94 current price, down 72.4% from its 52-week high of $10.66 and down 35.8% over the past 30 days. The company's fundamentals show Revenue of $72,765,415.00 (latest quarter) but Net income of $-3,385,558.00, with the company unprofitable over its most recent full fiscal year. The confluence of coordinated insider buying during a severe drawdown warrants investor attention.